Clostridioides difficile in inflammatory bowel disease | Medical Laboratory Observer
European Crohn´s and Colitis Organisation - ECCO - ECCO Guidelines
Y-ECCO (@Y_ECCO_IBD) / X
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease - Rodríguez‐Lago - 2023 - United European Gastroenterology Journal - Wiley Online Library
First Quantum Blue® Infliximab Poster presented at ECCO 2016
Latest IBDoc® Publications from ECCO 2019 | IBDoc
Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review - eClinicalMedicine
European Crohn's and Colitis Organisation (ECCO) 2016 Congress
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
PDF] ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. | Semantic Scholar
ECCO Congress | efcca.org
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
IJMS | Free Full-Text | Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
Management of inflammatory bowel disease in the elderly: A review - Digestive and Liver Disease
European Crohn´s and Colitis Organisation - ECCO - ECCO News
Ulcerative Colitis (UC) needs innovation
ECCO IBD by OCEAiN Organisation, Congress, Emotion, Association, iNnovation GmbH
Current best practice for disease activity assessment in IBD | Nature Reviews Gastroenterology & Hepatology
Canadian Association of Gastroenterology - Cutting edge IBD data from #DDW2017 just added to the CAG/Takeda IBD Update Slide Library! Check out www.ibdupdate.ca for rapid access to IBD slides from DDW 2016,
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
News | efcca.org
Ulcerative colitis - The Lancet
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today